RSNA 2008 

Abstract Archives of the RSNA, 2008


VB31-11

Evaluation of Additional Ultrasound to Mammography in Case of Breast Density ACR III/IV: Is There a Higher Detection Rate of Breast Cancer? Analysis of 102744 Diagnostic Processes

Scientific Papers

Presented on December 2, 2008
Presented as part of VB31: Breast Series: Identification and Management of the Patient at High Risk for Breast Cancer

Participants

Fritz K.W. Schaefer MD, Presenter: Nothing to Disclose
Alexander Katalinic MD, Abstract Co-Author: Nothing to Disclose
Philipp J. Schaefer MD, Abstract Co-Author: Nothing to Disclose
Christine Wefelnberg, Abstract Co-Author: Nothing to Disclose
Berndt Order, Abstract Co-Author: Nothing to Disclose
Ingrid Schreer MD, Abstract Co-Author: Nothing to Disclose
Walter Jonat MD, Abstract Co-Author: Nothing to Disclose
et al, Abstract Co-Author: Nothing to Disclose

PURPOSE

To evaluate additional ultrasound (US) examination to mammography in case of breast density ACR III and IV, in symptomatic women or women at risk. All patients were examined in the project “quality assurance in breast cancer diagnosis” (QuaMaDi project) in Schleswig Holstein, Germany. The process-orientated and comprehensive quality management project was implemented to improve the standard of breast cancer diagnosis.

METHOD AND MATERIALS

A prospective cohort with a total of 59514 patients and 102744 mammograms was initiated between 2001 and 2005. Breast US was indicated in all women with breast density ACR III and IV, in case of a suspicious clinical examination, and in case of masses or asymmetry in mammography. Abnormalities were defined positive, if biopsy findings revealed malignancy, and negative, if biopsy findings or all examinations turned out to be benign.

RESULTS

In total, 1019 breast cancers were detected. 116 mammographically occult breast cancers were diagnosed by ultrasound out of 62006 cases (1.9/1000 cases). Thus, mammography plus US detected 12.8% (116/903) breast cancers more than mammography alone did (903). In group ACR III/IV, 611 breast cancers were detected. Thus, mammography plus US detected 15.9% (84/527) breast cancers more than mammography alone (527).

CONCLUSION

For ACR III and IV, supplementary US to mammography vs mammography alone resulted in a significant increase of breast cancer detection rate of 15.9%.

CLINICAL RELEVANCE/APPLICATION

US is essential in detection of breast cancer in case of ACR III and IV.

Cite This Abstract

Schaefer, F, Katalinic, A, Schaefer, P, Wefelnberg, C, Order, B, Schreer, I, Jonat, W, et al, , Evaluation of Additional Ultrasound to Mammography in Case of Breast Density ACR III/IV: Is There a Higher Detection Rate of Breast Cancer? Analysis of 102744 Diagnostic Processes.  Radiological Society of North America 2008 Scientific Assembly and Annual Meeting, February 18 - February 20, 2008 ,Chicago IL. http://archive.rsna.org/2008/6016643.html